Biomolipon Injection 600 mg/ampoule (ALA) is a naturally occurring compound that functions as an antioxidant. It is involved in mitochondrial energy production and is known for its ability to regenerate other antioxidants like vitamins C and E. ALA is used as a dietary supplement for its potential health benefits.
Biomolipon Injection 600 mg/ampoule is commonly used for:
| Brand Name | Biomolipon |
|---|---|
| Type | Injection |
| Weight | 600 mg/ampoule |
| Generic | Alpha Lipoic Acid |
| Manufacturer | ZAS Corporation |
| Available in | English বাংলা |
Biomolipon Injection 600 mg/ampoule acts as an antioxidant by neutralizing free radicals and reducing oxidative stress. It also plays a role in mitochondrial energy production by participating in the conversion of glucose into energy. Additionally, ALA helps regenerate other antioxidants, such as glutathione, which further enhances its protective effects.
The effects of Biomolipon Injection 600 mg/ampoule can vary depending on the condition being treated. For diabetic neuropathy, improvements may be observed within a few weeks to several months of consistent use. General antioxidant benefits and metabolic support may also take several weeks to manifest.
Biomolipon Injection 600 mg/ampoule is well absorbed from the gastrointestinal tract when taken orally. It has high bioavailability and can cross the blood-brain barrier, allowing it to exert its effects throughout the body.
Biomolipon Injection 600 mg/ampoule is primarily metabolized in the liver. Its metabolites are then excreted in the urine. A small amount is also eliminated through feces.
Typical dosages of Biomolipon Injection 600 mg/ampoule for various conditions are:
Biomolipon Injection 600 mg/ampoule is commonly administered orally in the form of capsules or tablets. It can be taken with or without food. For specific medical conditions, it is best to follow the dosage recommendations provided by a healthcare provider.
Biomolipon Injection 600 mg/ampoule is generally considered safe when taken at recommended dosages. High doses may lead to gastrointestinal symptoms or allergic reactions. Toxicity is rare but should be monitored, especially in individuals with pre-existing health conditions.
- Consult a healthcare provider before starting Biomolipon Injection 600 mg/ampoule, particularly if you have diabetes, liver disease, or are pregnant or breastfeeding. - Monitor blood sugar levels regularly if using Biomolipon Injection 600 mg/ampoule to manage diabetic neuropathy, as it may affect insulin sensitivity.
Biomolipon Injection 600 mg/ampoule may interact with other medications, including:
- Diabetes: Monitor blood glucose levels closely, as ALA may affect insulin sensitivity. - Liver Disease: Use with caution and consult a healthcare provider for appropriate dosing.
- Antidiabetic Medications: ALA may enhance the effects of these drugs, increasing the risk of hypoglycemia. - Chemotherapy Agents: ALA may affect the efficacy of certain cancer treatments; consult with a healthcare provider.
There are no significant food interactions with Biomolipon Injection 600 mg/ampoule. However, it is recommended to take it on an empty stomach for optimal absorption.
Biomolipon Injection 600 mg/ampoule is classified as Category C for pregnancy. Its safety during pregnancy has not been established, so it should be used only if the benefits outweigh the risks. Consult with a healthcare provider before use.
It is not known if Biomolipon Injection 600 mg/ampoule is excreted in breast milk. Use during lactation should be approached with caution and under the guidance of a healthcare provider.
Acute overdose of Biomolipon Injection 600 mg/ampoule may lead to gastrointestinal symptoms such as nausea and vomiting. In case of suspected overdose, seek medical attention immediately.
Biomolipon Injection 600 mg/ampoule should be avoided in individuals with known hypersensitivity to the compound. It should also be used with caution in individuals with thyroid disorders or those on thyroid medication.
Follow the dosage instructions provided by a healthcare provider. Typically, Biomolipon Injection 600 mg/ampoule is taken orally in capsule or tablet form. It should be taken with water and can be taken with or without food.
Store Biomolipon Injection 600 mg/ampoule in a cool, dry place, away from direct sunlight and moisture. Keep it out of reach of children.
The volume of distribution of Biomolipon Injection 600 mg/ampoule is not well-defined but is known to be distributed widely throughout the body, including the brain and other tissues.
The half-life of Biomolipon Injection 600 mg/ampoule is approximately 30-50 minutes. This short half-life necessitates multiple doses throughout the day for optimal effect.
Biomolipon Injection 600 mg/ampoule is primarily cleared from the body through renal excretion. The clearance rate can be influenced by factors such as liver and kidney function.
See in details version Biomolipon Injection 600 mg/ampoule also Biomolipon Injection 600 mg/ampoule in bangla
Prof. Dr. Shaila Perveen
Gastroenterology (Stomach, Liver, Gallbladder, Pancreas) & Medicine Specialist